Literature DB >> 1826691

Impact of left ventricular hypertrophy on ventricular arrhythmias in the absence of coronary artery disease.

J K Ghali1, S Kadakia, R S Cooper, Y L Liao.   

Abstract

Left ventricular hypertrophy has a grave prognosis. Ventricular arrhythmias may account for a large portion of this poor prognosis, but the contribution of coronary artery disease has not been excluded. The occurrence of ventricular arrhythmias was investigated by 24 h ambulatory electrocardiographic (ECG) monitoring in 49 hypertensive patients who had normal findings on coronary arteriography. The presence of left ventricular hypertrophy was assessed by both ECG and echocardiography. The frequency and complexity of ventricular arrhythmias were significantly related to the presence of left ventricular hypertrophy whether it was defined by wall thickness (interventricular septum or posterior wall greater than or equal to 1.2 cm) or by left ventricular mass indexed to height (left ventricular mass/height greater than or equal to 163 g/m in men and greater than or equal to 121 g/m in women). The relation between left ventricular mass or wall thickness to ventricular arrhythmia was graded and continuous; for every 1 mm increase in the thickness of interventricular septum or posterior wall there was an associated two- to threefold increase, respectively, in the occurrence and complexity of ventricular arrhythmias. In conclusion, left ventricular hypertrophy is associated with an increase in the frequency and complexity of ventricular arrhythmias in the absence of coronary artery disease, and the relation is graded and continuous.

Entities:  

Mesh:

Year:  1991        PMID: 1826691     DOI: 10.1016/s0735-1097(10)80135-4

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  29 in total

Review 1.  Regression of left ventricular hypertrophy; what are appropriate therapeutic objectives?

Authors:  D J Sheridan; M P Kingsbury; N A Flores
Journal:  Br J Clin Pharmacol       Date:  1999-02       Impact factor: 4.335

Review 2.  Is the 'athlete's heart' arrhythmogenic? Implications for sudden cardiac death.

Authors:  Thomas Rowland
Journal:  Sports Med       Date:  2011-05-01       Impact factor: 11.136

Review 3.  Diagnosis and management of ventricular tachycardia.

Authors:  M Dancy
Journal:  Postgrad Med J       Date:  1992-06       Impact factor: 2.401

Review 4.  Hypertension, hypertrophy, heart failure.

Authors:  M G Nicholls
Journal:  Heart       Date:  1996-11       Impact factor: 5.994

Review 5.  A potential role for integrin signaling in mechanoelectrical feedback.

Authors:  Borna E Dabiri; Hyungsuk Lee; Kevin Kit Parker
Journal:  Prog Biophys Mol Biol       Date:  2012-07-20       Impact factor: 3.667

6.  Usefulness of echocardiography for predicting ventricular tachycardia detected by implantable loop recorder in syncope patients.

Authors:  Mathilde Musoni Falsing; Phillip Brainin; Ditte Madsen Andersen; Charlotte Ellen Larroudé; Tommi Bo Lindhart; Daniel Modin; Kirstine Ravnkilde; Emil Høegholm Karsum; Gunnar Gislason; Tor Biering-Sørensen
Journal:  Int J Cardiovasc Imaging       Date:  2021-05-28       Impact factor: 2.357

Review 7.  Association of ADHD medications with the risk of cardiovascular diseases: a meta-analysis.

Authors:  Hui Liu; Wenjing Feng; Dongfeng Zhang
Journal:  Eur Child Adolesc Psychiatry       Date:  2018-08-24       Impact factor: 4.785

Review 8.  Increased left ventricular mass as a predictor of sudden cardiac death: is it time to put it to the test?

Authors:  Steven M Stevens; Kyndaron Reinier; Sumeet S Chugh
Journal:  Circ Arrhythm Electrophysiol       Date:  2013-02

9.  Intramural Reentrant Ventricular Tachycardia in a Patient with Severe Hypertensive Left Ventricular Hypertrophy.

Authors:  Chin-Yu Lin; Fa-Po Chung; Yenn-Jiang Lin; Shih-Ann Chen
Journal:  Korean Circ J       Date:  2015-11-25       Impact factor: 3.243

Review 10.  Does a reduction in left ventricular hypertrophy reduce cardiovascular morbidity and mortality?

Authors:  F H Messerli; F Soria
Journal:  Drugs       Date:  1992       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.